Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDGL

Madrigal Pharmaceuticals Inc

Jun 18 • 04:00PM ET

505.75

+5.89 1.18 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: BBIO VKTX BMRN EXEL INCY KRYS ALNY RARE REGN VRTX

| Held by: VTI VB IWM VBK XBI VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-12.80	Insider Own	5.88%	Shs Outstand	23.04M	Perf Week	6.64%
Market Cap	11.66B	Forward P/E	49.39	EPS next Y	10.24	Insider Trans	-4.45%	Shs Float	21.70M	Perf Month	-1.19%
Enterprise Value	11.19B	PEG	-	EPS next Q	-2.58	Inst Own	105.13%	Short Float	17.62%	Perf Quarter	11.34%
Income	-309.44M	P/S	10.30	EPS this Y	46.35%	Inst Trans	2.70%	Short Ratio	12.23	Perf Half Y	-8.80%
Sales	1.13B	P/B	21.44	EPS next Y	248.54%	ROA	-27.83%	Short Interest	3.82M	Perf YTD	-13.15%
Book/sh	23.59	P/C	14.26	EPS next 5Y	-	ROE	-49.35%	52W High	615.00 -17.76%	Perf Year	78.89%
Cash/sh	35.48	P/FCF	-	EPS past 3/5Y	9.32% 0.37%	ROIC	-34.80%	52W Low	275.00 83.91%	Perf 3Y	107.20%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	92.94%	Volatility	4.14% 4.06%	Perf 5Y	380.71%
Dividend TTM	-	EV/Sales	9.88	EPS Y/Y TTM	29.06%	Oper. Margin	-27.68%	ATR (14)	20.36	Perf 10Y	4150.00%
Dividend Ex-Date	-	Quick Ratio	3.16	Sales Y/Y TTM	256.82%	Profit Margin	-27.32%	RSI (14)	53.42	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	3.50	EPS Q/Q	1.93%	SMA20	2.43%	Beta	-1.03	Target Price	678.80
Payout	-	Debt/Eq	0.64	Sales Q/Q	126.84%	SMA50	-0.79%	Rel Volume	1.56	Prev Close	499.86
Employees	915	LT Debt/Eq	0.64	Earnings	May 06 BMO	SMA200	2.51%	Avg Volume	312.62K	Price	505.75
IPO	Feb 06, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.16% 3.42%	Trades		Volume	486,887	Change	1.18%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)